SeekingAlpha · Sep 11, 2026
State Street: 6.8% Preferred Dividend Yield Is Too Good To Ignore
State Street posted robust Q2 results, boosting full-year guidance and reaffirming compelling mid-term earnings targets. Read why STT stock is a buy.
NYSE · STT
State Street Corporation
Financial Services · Asset Management
$183.07
Down-$1.16 (-0.63%)
Updated Sep 18, 2026, 6:48 PM
SID Score
7.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 36.2B
- P/E ratio
- 12.33
- Dividend yield
- 1.70%
- 52-week range
- $116.15 – $195.93
- Volume
- 1.46M
- Avg. volume
- 1.85M
Price performance
STT price history
1M range · 0 trading sessions · Daily adjusted prices
STT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest STT news
The latest Smart Investors Daily articles mentioning STT.
Stock researchCompany · Overview
STT research
Overview
Company profile and research snapshot.
Company profile
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $49 trillion in assets under custody and administration, and $5.1 trillion in assets under management, as of June 30, 2025, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $138.25
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | JP Morgan | Neutral | — |
| Jul 20, 2026 | Evercore ISI Group | Outperform | — |
| Jul 17, 2026 | Morgan Stanley | Overweight | — |
| Jul 17, 2026 | Keefe, Bruyette & Woods | Outperform | — |
| Jul 17, 2026 | Truist Securities | Hold | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 10, 2026
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH
Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.
Yahoo · Sep 10, 2026
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?
FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.
Yahoo · Sep 8, 2026
10 Investment Must Reads for This Week (Sept. 8, 2026)
Some investors are letting AI agents do their investing, but skeptics worry about the risks. State Street and UC Investments have launched an “endowment inspired” ETF. These are among the investment must reads for financial advisors this week.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
